Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
2 Adrenergic signaling in cardiomyocytes 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
3 Adrenergic signaling in cardiomyocytes 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
4 Aldosterone synthesis and secretion 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
5 Aldosterone-regulated sodium reabsorption 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
6 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 D01115 💬 Eplerenone 4件: 75, 113, 210, 215 💬
7 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 D00443 💬 Spironolactone 7件: 58, 67, 86, 113, 210, 218, 225 💬
8 Alzheimer disease 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
9 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
10 AMPK signaling pathway 💬
1件: ADRA1A 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
11 AMPK signaling pathway 💬
1件: ADRA1A 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
12 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
13 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
14 Bile secretion 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
15 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
16 Calcium signaling pathway 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
17 Calcium signaling pathway 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
18 Calcium signaling pathway 💬
2件: AVPR1A, AVPR1B 💬 D00101 💬 Vasopressin 1件: 210 💬
19 Calcium signaling pathway 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
20 Calcium signaling pathway 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
21 Calcium signaling pathway 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
22 Calcium signaling pathway 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
23 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
24 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
25 cAMP signaling pathway 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
26 cAMP signaling pathway 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
27 cAMP signaling pathway 💬
1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
28 cAMP signaling pathway 💬
1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
29 cAMP signaling pathway 💬
1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
30 Carbohydrate digestion and absorption 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
31 Cardiac muscle contraction 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
32 cGMP-PKG signaling pathway 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
33 cGMP-PKG signaling pathway 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
34 cGMP-PKG signaling pathway 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
35 cGMP-PKG signaling pathway 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
36 cGMP-PKG signaling pathway 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
37 cGMP-PKG signaling pathway 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
38 cGMP-PKG signaling pathway 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
39 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
40 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
41 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
42 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D10027 💬 Udenafil 2件: 86, 210 💬
43 Chagas disease 💬
1件: ACE 💬 D00621 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
44 Chagas disease 💬
1件: ACE 💬 D07892 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
45 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
46 Chemical carcinogenesis - receptor activation 💬
2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
47 Chemical carcinogenesis - receptor activation 💬
2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
48 Complement and coagulation cascades 💬
1件: F10 💬 D07086 💬 Rivaroxaban 5件: 46, 49, 75, 91, 210 💬
49 Coronavirus disease - COVID-19 💬
1件: ACE 💬 D00621 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
50 Coronavirus disease - COVID-19 💬
1件: ACE 💬 D07892 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
51 Diabetic cardiomyopathy 💬
1件: ACE 💬 D00621 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
52 Diabetic cardiomyopathy 💬
1件: ACE 💬 D07892 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
53 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
54 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
55 Endocrine and other factor-regulated calcium reabsorption 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
56 Gap junction 💬
1件: ADRB1 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
57 Gap junction 💬
1件: ADRB1 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
58 Gap junction 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
59 Gastric acid secretion 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
60 Human cytomegalovirus infection 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
61 Human papillomavirus infection 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
62 Huntington disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
63 Hypertrophic cardiomyopathy 💬
1件: ACE 💬 D00621 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
64 Hypertrophic cardiomyopathy 💬
1件: ACE 💬 D07892 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
65 IL-17 signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
66 Insulin secretion 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
67 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
68 Leishmaniasis 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
69 Melanogenesis 💬
1件: EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
70 Melanogenesis 💬
1件: EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
71 Melanogenesis 💬
1件: EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
72 Metabolic pathways 💬
1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
73 Metabolic pathways 💬
1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
74 Metabolic pathways 💬
1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
75 Metabolic pathways 💬
1件: PDE5A 💬 D10027 💬 Udenafil 2件: 86, 210 💬
76 Metabolic pathways 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
77 MicroRNAs in cancer 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
78 Mineral absorption 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
79 Neuroactive ligand-receptor interaction 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
80 Neuroactive ligand-receptor interaction 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
81 Neuroactive ligand-receptor interaction 💬
3件: AVPR1A, AVPR1B, AVPR2 💬 D00101 💬 Vasopressin 1件: 210 💬
82 Neuroactive ligand-receptor interaction 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
83 Neuroactive ligand-receptor interaction 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
84 Neuroactive ligand-receptor interaction 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
85 Neuroactive ligand-receptor interaction 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
86 Neuroactive ligand-receptor interaction 💬
1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
87 Neuroactive ligand-receptor interaction 💬
2件: THRA, THRB 💬 D01011 💬 Liothyronine 4件: 13, 78, 210, 212 💬
88 Neuroactive ligand-receptor interaction 💬
2件: THRA, THRB 💬 D08128 💬 Liothyronine 4件: 13, 78, 210, 212 💬
89 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
90 Ovarian steroidogenesis 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
91 Oxytocin signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
92 Pancreatic secretion 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
93 Parkinson disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
94 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
95 Pathways in cancer 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
96 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
97 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
98 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
99 Pathways in cancer 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
100 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
101 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
102 Phagosome 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
103 Phospholipase D signaling pathway 💬
3件: AVPR1A, AVPR1B, AVPR2 💬 D00101 💬 Vasopressin 1件: 210 💬
104 Platelet activation 💬
1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
105 Platelet activation 💬
1件: PTGS1 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
106 Prion disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
107 Protein digestion and absorption 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
108 Proximal tubule bicarbonate reclamation 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
109 Purine metabolism 💬
1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
110 Purine metabolism 💬
1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
111 Purine metabolism 💬
1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
112 Purine metabolism 💬
1件: PDE5A 💬 D10027 💬 Udenafil 2件: 86, 210 💬
113 Regulation of lipolysis in adipocytes 💬
2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
114 Regulation of lipolysis in adipocytes 💬
2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
115 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
116 Relaxin signaling pathway 💬
1件: EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
117 Relaxin signaling pathway 💬
1件: EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
118 Relaxin signaling pathway 💬
1件: EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
119 Renin secretion 💬
1件: ACE 💬 D00621 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
120 Renin secretion 💬
1件: ACE 💬 D07892 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
121 Renin secretion 💬
2件: ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
122 Renin secretion 💬
2件: ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
123 Renin secretion 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
124 Renin secretion 💬
1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
125 Renin secretion 💬
1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
126 Renin secretion 💬
1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
127 Renin-angiotensin system 💬
1件: ACE 💬 D00621 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
128 Renin-angiotensin system 💬
1件: ACE 💬 D07892 💬 Enalapril 6件: 19, 46, 66, 113, 210, 222 💬
129 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
130 Salivary secretion 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
131 Salivary secretion 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
132 Salivary secretion 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
133 Salmonella infection 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D00570 💬 Colchicine 7件:  2 , 42, 46, 56, 93, 210, 266 💬
134 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
135 Small cell lung cancer 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
136 Thyroid hormone signaling pathway 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
137 Thyroid hormone signaling pathway 💬
2件: THRA, THRB 💬 D01011 💬 Liothyronine 4件: 13, 78, 210, 212 💬
138 Thyroid hormone signaling pathway 💬
2件: THRA, THRB 💬 D08128 💬 Liothyronine 4件: 13, 78, 210, 212 💬
139 Thyroid hormone synthesis 💬
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 D00298 💬 Digoxin 3件:  8 , 46, 210 💬
140 TNF signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
141 Vascular smooth muscle contraction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00255 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
142 Vascular smooth muscle contraction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D03415 💬 Carvedilol 5件:  6 , 57, 86, 113, 210 💬
143 Vascular smooth muscle contraction 💬
2件: AVPR1A, AVPR1B 💬 D00101 💬 Vasopressin 1件: 210 💬
144 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
145 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
146 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
147 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
148 Vascular smooth muscle contraction 💬
1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
149 Vasopressin-regulated water reabsorption 💬
1件: AVPR2 💬 D00101 💬 Vasopressin 1件: 210 💬
150 VEGF signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬